SCHEMBL4696905

SCHEMBL4696905

CCCCCOc1cc(Br)c(-c2ccc(OC)cc2Cl)nc1NC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.41
CNR1 P21554 2/20 0.37
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
CYSLTR2 Q9NS75 1/20 0.35
CYSLTR1 Q9Y271 1/20 0.35
CDC7 O00311 1/20 0.35
DBF4 Q9UBU7 1/20 0.35
PIK3CD O00329 1/20 0.35
S1PR4 O95977 1/20 0.34
GCGR P47871 1/20 0.34
LIMK1 P53667 1/20 0.34
LIMK2 P53671 1/20 0.34
EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204591 0.83 CRHR1 (0.43) CRHR1CNR1HSP90AA1HSP90AB1CDC7
SCHEMBL4696317 0.83 CNR1 (0.44) CRHR1CNR1GCGR
SCHEMBL6204093 0.82 CRHR1 (0.42) CRHR1CNR1HSP90AA1HSP90AB1CDC7
SCHEMBL6201218 0.82 CRHR1 (0.42) CRHR1CNR1HSP90AA1HSP90AB1CDC7
SCHEMBL5517800 0.82 CRHR1 (0.46) CRHR1HSP90AA1HSP90AB1CDC7DBF4
SCHEMBL6203666 0.81 CRHR1 (0.50) CRHR1CNR1
SCHEMBL6204671 0.80 CRHR1 (0.49) CRHR1CNR1HSP90AA1HSP90AB1CDC7
SCHEMBL6201596 0.79 CRHR1 (0.48) CRHR1CNR1CDC7DBF4
SCHEMBL6204028 0.79 CRHR1 (0.48) CRHR1CNR1CDC7DBF4
SCHEMBL6203747 0.75 CRHR1 (0.44) CRHR1CNR1MAPTLIMK1LIMK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871762-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2008-01-02 EP disclosed
WO-2006113704-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2006-10-26 WO disclosed